| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |